70
Views
19
CrossRef citations to date
0
Altmetric
Special Features

Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women

, , , , &
Pages 214-221 | Received 01 Aug 2003, Accepted 01 Sep 2004, Published online: 21 Dec 2017

References

  • Consensus development conference (1991). Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 90: 107–110.
  • KanisJAAn update on the diagnosis and assessment of osteoporosis with densitometryOsteoporosis International20001119220210.1007/s001980050281
  • Department of Health and the Association of the British Pharmaceutical Industry (1994). Guidelines for the Economic Evaluation of Pharmaceuticals (Press release). Department of Health: London.
  • DolanPTorgersonDJThe cost of treating osteoporotic fractures in the United Kingdom female populationOsteoporosis Int1998861161710.1007/s001980050107
  • NICE FAD Reference National Institute for Clinical Excellence (2004). Appraisal Consultation Document: The Clinical Effectiveness and Cost Effectiveness of Technologies for the Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women. National Institute for Clinical Excellence: London, Available from: http://www.nice.org.uk.
  • DrummondMFMethods for the Economic Evaluation of Health Care Programmes1997
  • WeinsteinMCStatsonWBFoundations of cost-effectiveness analysis for health and medical practicesN Eng J Med197729671610.1056/NEJM197703312961304
  • BirchSGafniACost-effectiveness/utility analyses: do current decision rules lead us where we want to be?J Health Econ19921127929610.1016/0167-6296(92)90004-K
  • RafteryJNICE: faster access to modern treatments? Analysis of guidance on health technologiesBMJ20013231300130310.1136/bmj.323.7324.1300
  • Briggs AH and Gray AM (1999). Handling uncertainty when performing economic evaluations of healthcare interventions. Health Technol Assess 3(2).
  • FenwickERepresenting uncertainty: the role of cost-effectiveness acceptability curvesHealth Econ20011077978710.1002/hec.635
  • EastmanRCModel of complications of NIDDM. Model construction and assumptionsDiabe Care19972072572710.2337/diacare.20.5.725
  • Department of Health (1995). Policy Appraisal and Health. Department of Health: London.
  • Government Actuary Department (1999). Expectation of life United Kingdom females. http://www.gad.gov.uk/Life_Tables/docs/whltukf.xls
  • Stevenson MD et al (2004). A systematic review and economic evaluation of interventions for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assessment, in press.
  • Netten A et al (1998). Unit costs of health and social care. Canterbury PSSRU, University of Kent: Canterbury, UK.
  • HM Treasury. GDP and GDP Deflators at Market Prices, 2000. http://www.hm-treasury.gov.uk/economic_data_and_tools/gdp_deflators/data-gdp-fig.cfm
  • MurrayCUtility following a fracture in a group of elderly womenQual Life Res200211642
  • National Osteoporosis Foundation (1998). Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Introduction. Osteoporosis Int 8: S7–S80.
  • OleksikAHealth-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fracturesJ Bone Miner Res2000151384139210.1359/jbmr.2000.15.7.1384
  • DolanPHealth-related quality of life of Colles' fracture patientsOsteoporosis Int1999919619910.1007/s001980050136
  • KanisJAThe risk and burden of vertebral fractures in SwedenOsteoporosis Int200415202610.1007/s00198-003-1463-7
  • HuttonJA new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancerPharmacoeconomics19969Suppl 282210.2165/00019053-199600092-00004
  • Kanis JA et al (2002). Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 6(29).
  • StinnettAAPaltielADEstimating CE ratios under second-order uncertaintyMed Decision Making19971748348910.1177/0272989X9701700414
  • StevensonMDGaussian Process modelling in conjunction with individual patient simulation modelling. A case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosisMed Decision Making2004248910010.1177/0272989X03261561
  • BriggsAUncertainty in cost-effectiveness modelsPharmacoeconomics20001747950010.2165/00019053-200017050-00006
  • KlotzbeucherCMPatients with prior fracture have a increased risk of future fractures: a summary of the literature and statistical synthesisJ Bone Miner Res20001572172710.1359/jbmr.2000.15.4.721
  • Todd CJ et al (1999). Anglian Audit of Hip Fracture 2. Cambridge Health Services Research Group, University of Cambridge: Cambridge.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.